Can Wegovy (Semaglutide) Cause Heart Palpitations?

What the Clinical Data Says About Semaglutide and Palpitations

If you have started Wegovy or Ozempic and noticed an occasional flutter or racing feeling in your chest, you are not imagining things. While palpitations are not listed as a primary adverse event in the major semaglutide trials, including the SUSTAIN and STEP programs, they do appear consistently in post-market surveillance reports from real-world users.

The FDA prescribing information for semaglutide classifies tachycardia as an uncommon but documented side effect, which is mechanistically related to the palpitation experience even if the two terms differ clinically. Meanwhile, the landmark SELECT cardiovascular outcomes trial, which enrolled more than 17,000 participants, found that semaglutide reduced major cardiac events by 20 percent in adults with established cardiovascular disease. That protective finding is meaningful, but it does not eliminate the possibility of transient rhythm complaints during treatment.

The short version: palpitations on semaglutide are real, relatively common during certain phases of treatment, and worth understanding rather than dismissing.

Why This Medication Can Affect Your Heart Rate

Semaglutide belongs to a class called GLP-1 receptor agonists. GLP-1 receptors are present not only in the gut and pancreas but also in cardiac tissue and the sinoatrial node, which is the heart's natural pacemaker. This means the drug can directly influence how fast your heart beats, not just as a byproduct of weight loss, but as a direct pharmacological effect.

Clinical studies show semaglutide raises resting heart rate by an average of two to four beats per minute. That may sound minor, but for people who are sensitive to internal sensations, even a small, sustained uptick can feel like palpitations.

Beyond direct cardiac receptor stimulation, several indirect mechanisms may also be at play. Nausea, a very common GLP-1 side effect, can lead to reduced fluid and food intake. This, in turn, lowers levels of potassium and magnesium, both of which play a direct role in maintaining stable heart rhythm. Rapid weight loss itself can temporarily alter cardiac geometry and electrical conduction patterns, adding another layer of complexity.

When Palpitations Are More Likely to Occur

Not all moments on semaglutide carry equal risk for palpitations. Knowing the higher-risk windows can help you prepare and recognize patterns worth tracking.

The first four to eight weeks of treatment, and the period immediately following each dose escalation, are when most people notice heart-related symptoms. This is when GLP-1 receptor stimulation is at its most novel to the body. Skipping meals or eating very little can provoke sympathetic nervous system responses that mimic or worsen palpitations. Concurrent use of caffeine, stimulant medications, or thyroid drugs can amplify the heart rate effects of GLP-1 agonists in meaningful ways. Individuals with a history of anxiety disorders, arrhythmia, or mitral valve prolapse may also have a lower threshold for noticing even modest rhythm changes.

Comparing Symptoms: Drug Effect vs. Emergency Warning Signs

One of the most useful skills for anyone on semaglutide is learning to distinguish a nuisance side effect from a symptom that demands same-day attention.

It is also worth noting that semaglutide carries a black-box warning for thyroid C-cell tumors, and thyroid dysfunction is itself a well-established cause of palpitations. If symptoms persist despite lifestyle adjustments, thyroid labs including TSH and free T4 are a reasonable part of any workup.

How Clinicians Evaluate This Symptom

If you report palpitations to your prescribing clinician, a standard workup will typically include a resting ECG, a thyroid panel, and a basic metabolic panel to check electrolyte levels. Your provider will also review any concurrent medications that might interact with semaglutide's cardiovascular effects.

For symptoms that do not resolve quickly, wearable heart monitors such as a Holter or extended patch monitor can correlate your subjective complaints with actual rhythm disturbances over days to weeks. This kind of objective data is far more useful than symptom descriptions alone.

If semaglutide is identified as the likely cause, clinicians will usually try a dose reduction or a slower titration schedule before considering discontinuation. Full discontinuation of a medication that offers significant cardiometabolic benefits is rarely the first move. A cardiologist referral becomes appropriate when palpitations recur across multiple dose levels or when imaging suggests structural heart changes.

Doctronic, which has facilitated more than 22 million AI consultations with a 99.2% treatment plan alignment with board-certified physicians, offers a practical starting point for patients who want guidance before, during, or after an in-person visit.

Practical Steps to Manage Mild Palpitations

For palpitations that do not come with red-flag symptoms, several straightforward strategies can reduce their frequency and severity.

Hydration is the single easiest lever to pull. Semaglutide's GI side effects make dehydration more likely, and even mild fluid depletion can destabilize heart rhythm. Pairing adequate water intake with potassium-rich and magnesium-rich foods, such as bananas, avocados, leafy greens, and nuts, addresses the electrolyte piece directly.

Keeping your weekly injection on a consistent day and time helps smooth out peak drug concentration spikes rather than creating repeated surges. Reducing or eliminating caffeine during dose escalation periods is a low-effort, low-risk adjustment that can make a meaningful difference for sensitive individuals.

Finally, keeping a brief symptom log with notes on timing, duration, associated activity, and food intake gives your clinician the kind of actionable, specific data needed to distinguish a drug effect from a coincidental cause. That information can change the entire trajectory of your evaluation and your treatment plan.

Frequently Asked Questions

How common are heart palpitations as a side effect of Wegovy or Ozempic?

Palpitations are not listed as a primary adverse event in major semaglutide trials, but they are reported in post-market surveillance. The FDA prescribing information does document tachycardia as an uncommon side effect, and many users report transient fluttering or racing sensations, particularly during the early weeks of treatment and after dose increases.

Do semaglutide-caused palpitations go away on their own over time?

For most people, mild palpitations improve as the body adjusts to the medication, typically within four to eight weeks after each dose escalation. Staying hydrated, maintaining electrolyte intake, and limiting caffeine can help speed up that adjustment. If palpitations persist or worsen beyond this window, speaking with a clinician is the appropriate next step.

Should I stop taking Wegovy if I feel my heart racing?

Do not stop the medication on your own without consulting your prescriber. A racing sensation alone, without chest pain, shortness of breath, dizziness, or fainting, may not warrant stopping treatment. Your clinician may suggest a slower titration schedule or lifestyle adjustments. However, if you experience any accompanying serious symptoms, seek medical attention right away.

Can semaglutide cause atrial fibrillation or other serious arrhythmias?

Current evidence does not establish semaglutide as a direct cause of atrial fibrillation. The SELECT trial, involving over 17,000 participants, showed the drug reduced major cardiac events by 20%. That said, any prolonged, irregular, or rapid palpitations lasting more than a few minutes should be evaluated promptly to rule out arrhythmias through an ECG or heart monitor.

Is it safe to take semaglutide if I already have a heart condition?

Semaglutide is actually approved for cardiovascular risk reduction in adults with established heart disease, based on strong clinical trial data. However, patients with arrhythmias or other cardiac conditions may have a lower threshold for noticing heart rate changes. A thorough discussion with your cardiologist or prescribing clinician before starting or continuing the medication is strongly recommended.

The Bottom Line

Mild heart palpitations on semaglutide are relatively common, pharmacologically explainable, and often manageable with hydration, electrolyte support, and a slower dose titration schedule. For most people, these sensations ease over time and do not signal a serious problem. However, the line between a nuisance side effect and a genuine cardiac warning sign matters enormously. Palpitations paired with chest pain, dizziness, shortness of breath, or fainting always call for prompt evaluation. Doctronic, the first AI legally authorized to practice medicine and available 24 hours a day for free consultations or affordable $39 video visits, can help you assess your symptoms quickly and connect you with licensed clinicians when needed. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.